Femasys Inc (FEMY)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $11.89M
Last updated: Nov 17, 2026 at 11:05 AM ET
Femasys Inc (FEMY) Stock Forecast
Analysts expect Femasys (FEMY) to earn -$2.60 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.09M. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Strong Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 1.33, inside the Strong Buy band below 1.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 66.7% |
| Buy | 1 | 33.3% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Strong Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 351.7%.
- Fiscal year ending Dec 31, 2026
- -$2.60
- EPS consensus, revenue $2.09M
- Fiscal year ending Dec 31, 2027
- -$2.13
- EPS consensus, revenue $9.44M
- Next report
- Mar 29, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$2.60 | -$3.03 to -$2.17 | 2 | $2.09M | $1.67M to $2.50M | 2 |
| Dec 31, 2027 | -$2.13 | -$2.59 to -$1.66 | 2 | $9.44M | $8.28M to $10.60M | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.48 | -$0.55 to -$0.42 | 5 | $701250 | $465500 to $945000 | 5 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 4 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$4.53.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$2.60 | -$2.60 | -$2.60 | -$2.57 | -$4.53 | N/A |
| Fiscal year ending Dec 31, 2027 | -$2.13 | -$2.13 | -$2.13 | -$5.80 | -$5.80 | N/A |
Frequently Asked Questions About FEMY
What is the FEMY stock forecast?
Consensus analyst estimates put Femasys's EPS at -$2.60 for the fiscal year ending Dec 31, 2026, on revenue of $2.09M. The consensus rating from 3 analysts is Strong Buy.
How do analysts rate FEMY stock?
Of 3 analysts covering Femasys, 2 rate it Strong Buy, 1 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Strong Buy.
What EPS do analysts expect from FEMY next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.60, with estimates from -$3.03 to -$2.17 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.13, with estimates from -$2.59 to -$1.66 from 2 analysts.
What revenue do analysts expect from Femasys next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.09M, with estimates from $1.67M to $2.50M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $9.44M, with estimates from $8.28M to $10.60M.
How many analysts cover FEMY?
3 analysts rate Femasys stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
FEMY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors